Reference health

Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews

https://doi.org/10.1007/s00482-015-0092-3
CiteStamped reference-health badge
23/23 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 23 checked references that resolve
resolves10.1517/14728214.2010.491509
Emerging therapies for fibromyalgia: an update
resolves10.1200/JOP.2011.000397
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
resolves10.3111/13696998.2010.547237
Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States
resolves10.1517/13543784.17.1.85
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
resolves10.1152/physrev.00004.2003
Role of Endogenous Cannabinoids in Synaptic Signaling
resolves10.1001/jama.2015.6199
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems
resolves10.1007/s00520-014-2138-y
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review
resolves10.7326/M14-2385
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
resolves10.1093/annonc/mdv138
Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
resolves10.1055/s-0032-1328689
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer
resolves10.1111/ecc.12260
QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist
resolves10.1111/j.1365-2354.2008.00917.x
Therapeutic use of<i>Cannabis sativa</i>on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
resolves10.1002/14651858.CD007786.pub2
Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood
resolves10.1093/annonc/mdq194
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
resolves10.1007/s00520-014-2392-z
Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting
resolves10.1186/1471-2288-12-129
Quality assessment of systematic reviews or meta-analyses of nursing interventions conducted by Korean reviewers
resolves10.1016/j.jclinepi.2008.10.009
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews
resolves10.6004/jnccn.2012.0048
Cannabinoids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
resolves10.1136/bmj.323.7303.16
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
resolves10.1016/j.arr.2014.01.007
Efficacy and safety of medical cannabinoids in older subjects: A systematic review
resolves10.1126/science.1115740
Identification and Functional Characterization of Brainstem Cannabinoid CB<sub>2</sub>Receptors
resolves10.1038/srep04813
A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting
resolves10.1001/jama.2015.6358
Cannabinoids for Medical Use
The 7 references without a DOI — listed, not checked
no DOI — not checkedAromataris E (2014) Joanna Briggs Institute Reviewers’ Manual: 2014 edition/Supplement. In:Joanna Briggs Institute
no DOI — not checkedHesketh PJ (2004) Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress. Oncology (Williston Park). 18:9–14
no DOI — not checkedHiggins J, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. Wiley-Blackwell, Hoboken
no DOI — not checkedHoch E, Bonnetn U, Thomasius R et al (2015) Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int 112:271–278
no DOI — not checkedKeeley PW (2009) Nausea and vomiting in people with cancer and other chronic diseases. BMJ Clin Evid 2009
no DOI — not checkedPalli SR, Grabner M, Quimbo RA et al (2015) The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting. Cancer Manag Res 7:175–188
no DOI — not checkedSmith LA, Azariah F, Lavender VT et al. (2015) Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev 11:CD009464
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1007/s00482-015-0092-3"><img src="https://citestamp.com/citestamped/10.1007/s00482-015-0092-3/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1007/s00482-015-0092-3/badge.svg)](https://citestamp.com/citestamped/10.1007/s00482-015-0092-3)